Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Glass

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
Molecular Pharmacology|June 6, 2015
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid ReceptorElham Khajehali, Daniel T Malone, Michelle Glass, et al.
The Journal of Biological Chemistry|July 26, 2006
Induction of Krox-24 by endogenous cannabinoid type 1 receptors in Neuro2A cells is mediated by the MEK-ERK MAPK pathway and is suppressed by the phosphatidylinositol 3-kinase pathwayE Scott Graham, Nicola Ball, Emma L Scotter, et al.
British Journal of Pharmacology|December 10, 2023
A quantitative pharmacology model for cannabinoid CB<sub>1</sub> receptor mediated by Gi/Gs protein competitionLiang Yang, David B Finlay, Hayley M Green, et al.
Biochemical Pharmacology|February 14, 2024
Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB<sub>1</sub> receptorBeth Ryalls, Monica Patel, Eric Sparkes, et al.
British Journal of Pharmacology|June 5, 2023
A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid (CBLiang Yang, Xiao Zhu, David B Finlay, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Determination of the Cannabinoid CB1 Receptor's Positive Allosteric Modulator Binding Site through Mutagenesis StudiesHayley M Green, Daniel M J Fellner, David B Finlay, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 16, 2024
Insight into the mechanism of action of ORG27569 at the cannabinoid type one receptor utilising a unified mathematical modelHayley M Green, Liang Yang, Xiao Zhu, et al.
Forensic Toxicology|August 23, 2016
The 2-alkyl-2<i>H</i>-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activitiesMitchell Longworth, Samuel D Banister, James B C Mack, et al.
Cannabis and Cannabinoid Research|September 2, 2017
Affinity and Efficacy Studies of Tetrahydrocannabinolic Acid A at Cannabinoid Receptor Types One and TwoJohn M McPartland, Christa MacDonald, Michelle Young, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 29, 2007
Cannabinoids stimulate prostaglandin production by human gestational tissues through a tissue- and CB1-receptor-specific mechanismMurray D Mitchell, Timothy A Sato, Anderson Wang, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Molecular Pharmacology|June 6, 2015
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid ReceptorElham Khajehali, Daniel T Malone, Michelle Glass, et al.
The Journal of Biological Chemistry|July 26, 2006
Induction of Krox-24 by endogenous cannabinoid type 1 receptors in Neuro2A cells is mediated by the MEK-ERK MAPK pathway and is suppressed by the phosphatidylinositol 3-kinase pathwayE Scott Graham, Nicola Ball, Emma L Scotter, et al.
British Journal of Pharmacology|December 10, 2023
A quantitative pharmacology model for cannabinoid CB<sub>1</sub> receptor mediated by Gi/Gs protein competitionLiang Yang, David B Finlay, Hayley M Green, et al.
Biochemical Pharmacology|February 14, 2024
Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB<sub>1</sub> receptorBeth Ryalls, Monica Patel, Eric Sparkes, et al.
British Journal of Pharmacology|June 5, 2023
A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid (CBLiang Yang, Xiao Zhu, David B Finlay, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Determination of the Cannabinoid CB1 Receptor's Positive Allosteric Modulator Binding Site through Mutagenesis StudiesHayley M Green, Daniel M J Fellner, David B Finlay, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 16, 2024
Insight into the mechanism of action of ORG27569 at the cannabinoid type one receptor utilising a unified mathematical modelHayley M Green, Liang Yang, Xiao Zhu, et al.
Forensic Toxicology|August 23, 2016
The 2-alkyl-2<i>H</i>-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activitiesMitchell Longworth, Samuel D Banister, James B C Mack, et al.
Cannabis and Cannabinoid Research|September 2, 2017
Affinity and Efficacy Studies of Tetrahydrocannabinolic Acid A at Cannabinoid Receptor Types One and TwoJohn M McPartland, Christa MacDonald, Michelle Young, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 29, 2007
Cannabinoids stimulate prostaglandin production by human gestational tissues through a tissue- and CB1-receptor-specific mechanismMurray D Mitchell, Timothy A Sato, Anderson Wang, et al.
Pageof 13